{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:36:15Z","timestamp":1761824175948,"version":"build-2065373602"},"reference-count":43,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.vaccine.2019.10.087","type":"journal-article","created":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T09:00:53Z","timestamp":1573117253000},"page":"882-889","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Cross-protective immune responses against African horse sickness virus after vaccination with protein NS1 delivered by avian reovirus muNS microspheres and modified vaccinia virus Ankara"],"prefix":"10.1016","volume":"38","author":[{"given":"Alejandro","family":"Mar\u00edn-L\u00f3pez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Barreiro-Pi\u00f1eiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Utrilla-Trigo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6433-3379","authenticated-orcid":false,"given":"Diego","family":"Barriales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Benavente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aitor","family":"Nogales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Mart\u00ednez-Costas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4275-7277","authenticated-orcid":false,"given":"Javier","family":"Ortego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Calvo-Pinilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.10.087_b0005","series-title":"African horse sickness in Infectious Diseases of Livestock","first-page":"1231","author":"Coetzer","year":"2004"},{"issue":"4","key":"10.1016\/j.vaccine.2019.10.087_b0010","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1051\/vetres:2004021","article-title":"African horse sickness","volume":"35","author":"Mellor","year":"2004","journal-title":"Vet Res"},{"issue":"6","key":"10.1016\/j.vaccine.2019.10.087_b0015","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1177\/030098589202900615","article-title":"Electron microscopic evidence for endothelial infection by African horsesickness virus","volume":"29","author":"Laegreid","year":"1992","journal-title":"Vet Pathol"},{"issue":"1","key":"10.1016\/j.vaccine.2019.10.087_b0020","first-page":"7","article-title":"A morphological study of the lesions of African horsesickness","volume":"50","author":"Newsholme","year":"1983","journal-title":"Onderstepoort J Vet Res"},{"key":"10.1016\/j.vaccine.2019.10.087_b0025","first-page":"7","article-title":"The transmission of bluetongue and horse sickness by Culicoides","volume":"19","author":"Du Toit","year":"1944","journal-title":"Onderstepoort J Vet Sci Anim Ind"},{"issue":"19","key":"10.1016\/j.vaccine.2019.10.087_b0030","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/vr.125.19.489-a","article-title":"African horse sickness in Saudi Arabia","volume":"125","author":"Anderson","year":"1989","journal-title":"Vet Rec"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2019.10.087_b0035","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0147-9571(94)90046-9","article-title":"African horse sickness virus structure","volume":"17","author":"Roy","year":"1994","journal-title":"Comp Immunol Microbiol Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2019.10.087_b0040","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1006\/viro.1993.1537","article-title":"Neutralizing epitopes of African horsesickness virus serotype 4 are located on VP2","volume":"196","author":"Burrage","year":"1993","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2019.10.087_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2017.04.005","article-title":"Vaccination with recombinant Modified Vaccinia Ankara (MVA) viruses expressing single African horse sickness virus VP2 antigens induced cross-reactive virus neutralising antibodies (VNAb) in horses when administered in combination","author":"Manning","year":"2017","journal-title":"Vaccine"},{"issue":"Pt 5","key":"10.1016\/j.vaccine.2019.10.087_b0050","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1099\/0022-1317-78-5-1077","article-title":"Characterization of tubular structures composed of nonstructural protein NS1 of African horsesickness virus expressed in insect cells","volume":"78","author":"Maree","year":"1997","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2019.10.087_b0055","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/1743-422X-9-178","article-title":"Bluetongue virus non-structural protein 1 is a positive regulator of viral protein synthesis","volume":"9","author":"Boyce","year":"2012","journal-title":"Virol J"},{"issue":"5","key":"10.1016\/j.vaccine.2019.10.087_b0060","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/s41564-019-0369-x","article-title":"Atomic structure of the translation regulatory protein NS1 of bluetongue virus","volume":"4","author":"Kerviel","year":"2019","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.vaccine.2019.10.087_b0065","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.virusres.2015.08.005","article-title":"Identification of CD8 T cell epitopes in VP2 and NS1 proteins of African horse sickness virus in IFNAR(-\/-) mice","volume":"210","author":"de la Poza","year":"2015","journal-title":"Virus Res"},{"issue":"12","key":"10.1016\/j.vaccine.2019.10.087_b0070","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.3201\/eid2212.160718","article-title":"African horse sickness caused by genome reassortment and reversion to virulence of live, attenuated vaccine viruses, South Africa, 2004\u20132014","volume":"22","author":"Weyer","year":"2016","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2019.10.087_b0075","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02023-18","article-title":"The interaction of bluetongue virus VP6 and Genomic RNA Is essential for genome packaging","volume":"93","author":"Sung","year":"2019","journal-title":"J Virol"},{"issue":"17","key":"10.1016\/j.vaccine.2019.10.087_b0080","doi-asserted-by":"crossref","first-page":"8764","DOI":"10.1128\/JVI.01052-15","article-title":"VP2 Exchange and NS3\/NS3a deletion in african horse sickness virus (AHSV) in development of disabled infectious single animal vaccine candidates for AHSV","volume":"89","author":"van de Water","year":"2015","journal-title":"J Virol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2019.10.087_b0085","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.vetimm.2012.06.009","article-title":"An African horse sickness virus serotype 4 recombinant canarypox virus vaccine elicits specific cell-mediated immune responses in horses","volume":"149","author":"El Garch","year":"2012","journal-title":"Vet Immunol Immunopathol"},{"issue":"1","key":"10.1016\/j.vaccine.2019.10.087_b0090","doi-asserted-by":"crossref","first-page":"e16503","DOI":"10.1371\/journal.pone.0016503","article-title":"A modified vaccinia Ankara virus (MVA) vaccine expressing African horse sickness virus (AHSV) VP2 protects against AHSV challenge in an IFNAR -\/- mouse model","volume":"6","author":"Castillo-Olivares","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2019.10.087_b0095","first-page":"177","article-title":"New generation of African horse sickness virus vaccines based on structural and molecular studies of the virus particles","volume":"14","author":"Roy","year":"1998","journal-title":"Arch Virol Suppl"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2019.10.087_b0100","doi-asserted-by":"crossref","first-page":"i130","DOI":"10.1093\/heapro\/dau032","article-title":"Evaluation of Health in All Policies: concept, theory and application","volume":"29","author":"Baum","year":"2014","journal-title":"Health Promot Int"},{"issue":"33","key":"10.1016\/j.vaccine.2019.10.087_b0105","doi-asserted-by":"crossref","first-page":"4434","DOI":"10.1016\/j.vaccine.2009.05.044","article-title":"Protective immunization of horses with a recombinant canarypox virus vectored vaccine co-expressing genes encoding the outer capsid proteins of African horse sickness virus","volume":"27","author":"Guthrie","year":"2009","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2019.10.087_b0110","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jbiotec.2011.07.010","article-title":"IC-tagged proteins are able to interact with each other and perform complex reactions when integrated into muNS-derived inclusions","volume":"155","author":"Brandariz-Nunez","year":"2011","journal-title":"J Biotechnol"},{"issue":"9","key":"10.1016\/j.vaccine.2019.10.087_b0115","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.1128\/JVI.02534-09","article-title":"Avian reovirus microNS protein forms homo-oligomeric inclusions in a microtubule-independent fashion, which involves specific regions of its C-terminal domain","volume":"84","author":"Brandariz-Nunez","year":"2010","journal-title":"J Virol"},{"issue":"11","key":"10.1016\/j.vaccine.2019.10.087_b0120","doi-asserted-by":"crossref","first-page":"e13961","DOI":"10.1371\/journal.pone.0013961","article-title":"A versatile molecular tagging method for targeting proteins to avian reovirus muNS inclusions. Use in protein immobilization and purification","volume":"5","author":"Brandariz-Nunez","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2019.10.087_b0125","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.antiviral.2014.07.008","article-title":"VP2, VP7, and NS1 proteins of bluetongue virus targeted in avian reovirus muNS-Mi microspheres elicit a protective immune response in IFNAR(-\/-) mice","volume":"110","author":"Marin-Lopez","year":"2014","journal-title":"Antiviral Res"},{"issue":"7","key":"10.1016\/j.vaccine.2019.10.087_b0130","doi-asserted-by":"crossref","first-page":"e70197","DOI":"10.1371\/journal.pone.0070197","article-title":"Ns1 Is a Key Protein in the Vaccine Composition to Protect Ifnar(-\/-) Mice against Infection with Multiple Serotypes of African Horse Sickness Virus","volume":"8","author":"de la Poza","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2019.10.087_b0135","first-page":"25","article-title":"Using IC-tagging methodology for production and purification of epitope-loaded protein microspheres for vaccination","volume":"1349","author":"Barreiro-Pineiro","year":"2016","journal-title":"MethodsMol Biol"},{"key":"10.1016\/j.vaccine.2019.10.087_b0140","first-page":"92(16)","article-title":"CD8 T Cell responses to an immunodominant epitope within the nonstructural protein NS1 provide wide immunoprotection against bluetongue virus in IFNAR(-\/-) Mice","author":"Marin-Lopez","year":"2018","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2019.10.087_b0145","first-page":"403","article-title":"A study of the role of cell-mediated immunity in bluetongue virus infection in sheep, using cellular adoptive transfer techniques","volume":"52","author":"Jeggo","year":"1984","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.vaccine.2019.10.087_b0150","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.2042-3306.2012.00590.x","article-title":"African horse sickness in naturally infected, immunised horses","volume":"45","author":"Weyer","year":"2013","journal-title":"Equine Vet J"},{"issue":"3","key":"10.1016\/j.vaccine.2019.10.087_b0155","doi-asserted-by":"crossref","first-page":"731","DOI":"10.20506\/rst.20.3.1306","article-title":"Using climate data to map the potential distribution of Culicoides imicola (Diptera: Ceratopogonidae) in Europe","volume":"20","author":"Wittmann","year":"2001","journal-title":"Rev Sci Tech"},{"issue":"Pt 6","key":"10.1016\/j.vaccine.2019.10.087_b0160","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1099\/0022-1317-77-6-1211","article-title":"Full protection against African horsesickness (AHS) in horses induced by baculovirus-derived AHS virus serotype 4 VP2, VP5 and VP7","volume":"77","author":"Martinez-Torrecuadrada","year":"1996","journal-title":"J Gen Virol"},{"issue":"Pt 9","key":"10.1016\/j.vaccine.2019.10.087_b0165","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1099\/0022-1317-77-9-2053","article-title":"Recombinant baculovirus-synthesized African horsesickness virus (AHSV) outer-capsid protein VP2 provides protection against virulent AHSV challenge","volume":"77","author":"Roy","year":"1996","journal-title":"J Gen Virol"},{"issue":"39","key":"10.1016\/j.vaccine.2019.10.087_b0170","doi-asserted-by":"crossref","first-page":"6505","DOI":"10.1016\/j.vaccine.2010.06.105","article-title":"In vivo cross-protection to African horse sickness Serotypes 5 and 9 after vaccination with Serotypes 8 and 6","volume":"28","author":"von Teichman","year":"2010","journal-title":"Vaccine"},{"issue":"29","key":"10.1016\/j.vaccine.2019.10.087_b0175","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1016\/j.vaccine.2014.04.036","article-title":"Vaccination of horses with a recombinant modified vaccinia Ankara virus (MVA) expressing African horse sickness (AHS) virus major capsid protein VP2 provides complete clinical protection against challenge","volume":"32","author":"Alberca","year":"2014","journal-title":"Vaccine"},{"issue":"22","key":"10.1016\/j.vaccine.2019.10.087_b0180","doi-asserted-by":"crossref","first-page":"10847","DOI":"10.1073\/pnas.89.22.10847","article-title":"Nonreplicating vaccinia vector efficiently expresses recombinant genes","volume":"89","author":"Sutter","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"39","key":"10.1016\/j.vaccine.2019.10.087_b0185","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1016\/j.vaccine.2013.03.020","article-title":"Clinical development of Modified Vaccinia virus Ankara vaccines","volume":"31","author":"Gilbert","year":"2013","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2019.10.087_b0190","doi-asserted-by":"crossref","first-page":"e35485","DOI":"10.1371\/journal.pone.0035485","article-title":"Systems analysis of MVA-C induced immune response reveals its significance as a vaccine candidate against HIV\/AIDS of clade C","volume":"7","author":"Gomez","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.vaccine.2019.10.087_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/ciq015","article-title":"Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1","volume":"52","author":"Berthoud","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2019.10.087_b0200","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.it.2003.11.009","article-title":"Jump-starting the immune system: prime-boosting comes of age","volume":"25","author":"Woodland","year":"2004","journal-title":"Trends Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2019.10.087_b0205","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/emmm.201403876","article-title":"Vaccines for the 21st century","volume":"6","author":"Delany","year":"2014","journal-title":"EMBO Mol Med"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2019.10.087_b0210","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0264-410X(01)00445-5","article-title":"The protective efficacy of a recombinant VP2-based African horsesickness subunit vaccine candidate is determined by adjuvant","volume":"20","author":"Scanlen","year":"2002","journal-title":"Vaccine"},{"issue":"44","key":"10.1016\/j.vaccine.2019.10.087_b0215","doi-asserted-by":"crossref","first-page":"6024","DOI":"10.1016\/j.vaccine.2017.04.005","article-title":"Vaccination with recombinant Modified Vaccinia Ankara (MVA) viruses expressing single African horse sickness virus VP2 antigens induced cross-reactive virus neutralising antibodies (VNAb) in horses when administered in combination","volume":"35","author":"Manning","year":"2017","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19314768?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19314768?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:37:55Z","timestamp":1759401475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19314768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0264410X19314768"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.10.087","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cross-protective immune responses against African horse sickness virus after vaccination with protein NS1 delivered by avian reovirus muNS microspheres and modified vaccinia virus Ankara","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.10.087","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}